Stockscreener 앱 받기
8.305
2.41%
-0.205
시장 영업 전:
8.10
-0.205
-2.47%
전일 마감가:
$8.51
열려 있는:
$8.41
하루 거래량:
387.00K
Relative Volume:
0.64
시가총액:
$181.97M
수익:
-
순이익/손실:
$-112.46M
주가수익비율:
-5.064
EPS:
-1.64
순현금흐름:
$-99.89M
1주 성능:
+4.47%
1개월 성능:
-59.61%
6개월 성능:
+81.57%
1년 성능:
-53.57%
1일 변동 폭
$8.03
$8.49
1주일 범위
$7.21
$8.66
52주 변동 폭
$2.622
$65.80
보 바이오파마 Stock (VOR) Company Profile
명칭
Vor Biopharma Inc
전화
617-655-6580
주소
500 BOYLSTON STREET, BOSTON
VOR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
8.305 | 186.46M | 0 | -112.46M | -99.89M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
보 바이오파마 Stock (VOR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-25 | 재개 | Wedbush | Neutral |
| 2025-10-15 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-09-24 | 업그레이드 | Stifel | Hold → Buy |
| 2025-06-30 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2022-07-26 | 개시 | Wedbush | Outperform |
| 2022-04-27 | 개시 | Goldman | Neutral |
| 2021-12-17 | 개시 | H.C. Wainwright | Buy |
| 2021-12-03 | 개시 | Robert W. Baird | Outperform |
| 2021-12-02 | 개시 | Oppenheimer | Outperform |
| 2021-10-19 | 개시 | JMP Securities | Mkt Outperform |
| 2021-03-25 | 개시 | B. Riley Securities | Buy |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-03-03 | 개시 | Evercore ISI | Outperform |
| 2021-03-02 | 개시 | Goldman | Sell |
| 2021-03-02 | 개시 | Stifel | Buy |
모두보기
보 바이오파마 주식(VOR)의 최신 뉴스
Will Vor Biopharma Inc. stock maintain momentum in 2025Gold Moves & Capital Efficiency Focused Strategies - Newser
What drives Vor Biopharma Inc stock priceEarnings Surprise Analysis & Superior Capital Trading Plans - earlytimes.in
Is There An Opportunity With Vor Biopharma Inc.'s (NASDAQ:VOR) 49% Undervaluation? - Yahoo Finance
Vor Biopharma Inc. (NASDAQ:VOR) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Form 424B3 Vor Biopharma Inc. - StreetInsider
Wedbush Predicts Vor Biopharma's Q4 Earnings (NASDAQ:VOR) - MarketBeat
How Vor Biopharma Inc. stock benefits from global expansionLayoff News & Fast Exit and Entry Strategy Plans - BỘ NỘI VỤ
Wedbush Begins Coverage on Vor Biopharma (NASDAQ:VOR) - MarketBeat
Vor Biopharma (VOR) Upgraded to Buy: Here's What You Should Know - sharewise.com
Wedbush Initiates Coverage on Vor Biopharma (VOR) with Neutral R - GuruFocus
Wedbush Boosts Price Target on Vor Biopharma to $9 From $0.40, Keeps Neutral Rating - MarketScreener
Wedbush Assumes Vor Biopharma, Inc. (VOR) at Neutral - StreetInsider
Vor Biopharma Inc. (VOR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Vor Biopharma Inc. stock attract more institutional investorsWeekly Trade Review & Capital Efficiency Focused Strategies - newser.com
Why retail investors favor Vor Biopharma Inc. stock2025 Technical Patterns & Free Community Supported Trade Ideas - newser.com
What technical signals suggest for Vor Biopharma Inc. stockQuarterly Profit Summary & Verified Momentum Stock Alerts - newser.com
Combining price and volume data for Vor Biopharma Inc.2025 Big Picture & Technical Confirmation Alerts - newser.com
How currency fluctuations impact Vor Biopharma Inc. stockFed Meeting & Real-Time Buy Signal Alerts - newser.com
Can a trend reversal in Vor Biopharma Inc. lead to recoveryWeekly Trade Summary & Low Risk Growth Stock Ideas - newser.com
Using data models to predict Vor Biopharma Inc. stock movementJuly 2025 Pullbacks & Low Drawdown Momentum Ideas - newser.com
Using Python tools to backtest Vor Biopharma Inc. strategiesJuly 2025 News Drivers & Daily Profit Maximizing Tips - newser.com
Forecasting Vor Biopharma Inc. price range with options dataAnalyst Upgrade & Stepwise Trade Execution Plans - newser.com
Why Vor Biopharma Inc. stock could benefit from AI revolutionRisk Management & Real-Time Chart Breakout Alerts - newser.com
Vor Biopharma Reports Q3 2025 Financial Results and Strategic Updates - MSN
Can Vor Biopharma Inc. stock beat analyst upgrades2025 AllTime Highs & Free Daily Entry Point Trade Alerts - newser.com
Risk adjusted return profile for Vor Biopharma Inc. analyzedTrade Exit Summary & Capital Efficient Trading Techniques - newser.com
Published on: 2025-11-16 14:39:57 - newser.com
보 바이오파마 (VOR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.10%
1.10%
자본화:
|
볼륨(24시간):